Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Good momentum in commercial CDMO business
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
The new Biolys provides higher concentration of L-lysine
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
Subscribe To Our Newsletter & Stay Updated
